Liver transplant may reverse artery damage in cirrhosis patients
NCT ID NCT07201649
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how liver cirrhosis and liver transplantation affect hardening of the arteries (arterial calcification). Researchers will measure a substance called pyrophosphate in the blood and urine of 95 people waiting for a liver transplant. They want to see if the transplant can stop or reverse artery hardening and restore normal pyrophosphate levels.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nice
RECRUITINGNice, Alpes-maritimes, 06200, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- A new procedure may offer relief for Cirrhosis-Related fluid buildup
- Can liver damage predict how drugs behave?
- Better crystal ball for liver crisis: new scores put to the test
- Blood thinner may stop early cirrhosis from turning deadly — a major trial puts it to the test
- Stick-On ultrasound patch could spot liver damage without a specialist